Safety and Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder
Public ClinicalTrials.gov record NCT01179516. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study Comparing the Efficacy and Safety of 2 Doses (10 and 15 mg) of Lu AA21004 in Acute Treatment of Adults With Major Depressive Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy, safety and tolerability of vortioxetine, once daily (QD), compared with placebo in adults with major depressive disorder.
Study identification
- NCT ID
- NCT01179516
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 469 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2010
- Primary completion
- Apr 30, 2012
- Completion
- May 31, 2012
- Last update posted
- Dec 17, 2013
2010 – 2012
United States locations
- U.S. sites
- 61
- U.S. states
- 29
- U.S. cities
- 61
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Carson | California | — | — |
| Not listed | Cerritos | California | — | — |
| Not listed | El Centro | California | — | — |
| Not listed | Fresno | California | — | — |
| Not listed | Glendale | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Oakland | California | — | — |
| Not listed | Oceanside | California | — | — |
| Not listed | San Diego | California | — | — |
| Not listed | Santa Ana | California | — | — |
| Not listed | Sherman Oaks | California | — | — |
| Not listed | Stanford | California | — | — |
| Not listed | Upland | California | — | — |
| Not listed | Denver | Colorado | — | — |
| Not listed | Hartford | Connecticut | — | — |
| Not listed | Hockessin | Delaware | — | — |
| Not listed | Fort Walton Beach | Florida | — | — |
| Not listed | Kissimmee | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Pompano Beach | Florida | — | — |
| Not listed | Atlanta | Georgia | — | — |
| Not listed | Hoffman Estates | Illinois | — | — |
| Not listed | Naperville | Illinois | — | — |
| Not listed | Oak Brook | Illinois | — | — |
| Not listed | Indianapolis | Indiana | — | — |
| Not listed | Lafayette | Indiana | — | — |
| Not listed | Newburgh | Indiana | — | — |
| Not listed | Prarie Ridge | Kansas | — | — |
| Not listed | Wichita | Kansas | — | — |
| Not listed | Baltimore | Maryland | — | — |
| Not listed | Fall River | Massachusetts | — | — |
| Not listed | Watertown | Massachusetts | — | — |
| Not listed | Clinton Township | Michigan | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Las Vegas | Nevada | — | — |
| Not listed | Nashua | New Hampshire | — | — |
| Not listed | Albuquerque | New Mexico | — | — |
| Not listed | Staten Island | New York | — | — |
| Not listed | Avon Lake | Ohio | — | — |
| Not listed | Beachwood | Ohio | — | — |
| Not listed | Canton | Ohio | — | — |
| Not listed | Garfield Heights | Ohio | — | — |
| Not listed | Toledo | Ohio | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Salem | Oregon | — | — |
| Not listed | Allentown | Pennsylvania | — | — |
| Not listed | Philadelphia | Pennsylvania | — | — |
| Not listed | Pittsburgh | Pennsylvania | — | — |
| Not listed | Lincoln | Rhode Island | — | — |
| Not listed | Columbia | South Carolina | — | — |
| Not listed | Franklin | Tennessee | — | — |
| Not listed | Dallas | Texas | — | — |
| Not listed | DeSoto | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Lake Jackson | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | The Woodlands | Texas | — | — |
| Not listed | Salt Lake City | Utah | — | — |
| Not listed | Roanoke | Virginia | — | — |
| Not listed | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01179516, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 17, 2013 · Synced Sep 13, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01179516 live on ClinicalTrials.gov.